Breakthrough HIV blocking medicine gets greenlight in SA
|
The "miracle tool" HIV medicine
lenacapavir will be sold in South Africa from as early as March or April 2026
according to gov. |
AbbVie's HIV Study: A Potential Game Changer in HIV Treatment
... Antiretroviral Therapy Undergoing Analytical Treatment Interruption. The study aims to assess changes in disease activity, adverse events, and ... View article...